Literature DB >> 6280897

Improved micromethod for assay of serum angiotensin converting enzyme.

H M Neels, S L Scharpé, M E van Sande, R M Verkerk, K J Van Acker.   

Abstract

We describe conditions for determining angiotensin converting enzyme (EC 3.4.15.1) in serum, by liquid chromatography. Serum (10 microL) is assayed with the artificial substrate hippuryl-glycyl-glycine (30 mmol/L) in a 50 mmol/L "HEPES" buffer solution with a high salt content (300 mmol of NaCl and 400 mmol of Na2SO4 per liter), at pH 8.0. The resulting enzymic activity is ninefold that of the currently popular spectrophotometric assay of Cushman and Cheung as modified by Lieberman (Am. J. Med. 59: 365-372, 1975). The hippuric acid end product is separated from the substrate by reversed-phase liquid chromatography and measured spectrophotometrically at 228 nm. o-Methyl hippuric acid is used as internal standard. The mean value for 100 normal control subjects was 317 (SD 96) nmol of hippuric acid released per milliliter of serum per minute. The enzyme activity is greater in newborns (p less than 0.05) and has a tendency to decrease with age. This partly automated method, which is optimized with regard to activity and detection, can be used in clinical routine.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280897

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  11 in total

1.  Assessing bone marrow cellularity.

Authors:  D O Ho-Yen
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

2.  Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood.

Authors:  T J Fiselier; P Lijnen; L Monnens; P van Munster; M Jansen; P Peer
Journal:  Eur J Pediatr       Date:  1983-10       Impact factor: 3.183

3.  Tripeptidylcarboxypeptidase activity of angiotensin I converting enzyme in human serum.

Authors:  H Neels; J Inokuchi; A Nagamatsu; M van Sande; S Scharpe
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

4.  Pseudohyponatremia and hyperviscosity.

Authors:  A A Nanji; D W Blank
Journal:  J Clin Pathol       Date:  1983-07       Impact factor: 3.411

5.  Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy Study.

Authors:  F Cambien; F Alhenc-Gelas; B Herbeth; J L Andre; R Rakotovao; M F Gonzales; J Allegrini; C Bloch
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

6.  Renal protective effect of enalapril in diabetic nephropathy.

Authors:  S Björck; H Mulec; S A Johnsen; G Nordén; M Aurell
Journal:  BMJ       Date:  1992-02-08

7.  Cardiovascular and autonomic phenotype of db/db diabetic mice.

Authors:  Danielle Senador; Keerthy Kanakamedala; Maria Claudia Irigoyen; Mariana Morris; Khalid M Elased
Journal:  Exp Physiol       Date:  2009-02-13       Impact factor: 2.969

8.  Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.

Authors:  Zia Shariat-Madar; Fakhri Mahdi; Mark Warnock; Jonathon W Homeister; Sujata Srikanth; Yelena Krijanovski; Laine J Murphey; Ayad A Jaffa; Alvin H Schmaier
Journal:  Blood       Date:  2006-03-02       Impact factor: 22.113

9.  Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis.

Authors:  K Furuya; E Yamaguchi; A Itoh; N Hizawa; N Ohnuma; J Kojima; N Kodama; Y Kawakami
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

10.  18F-FDG PET, genotype-corrected ACE and sIL-2R in newly diagnosed sarcoidosis.

Authors:  Ruth G Keijsers; Fred J Verzijlbergen; Wim J Oyen; Jules M van den Bosch; Henk J Ruven; Heleen van Velzen-Blad; Jan C Grutters
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-04       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.